Trulicity Dosing, Doses, and Injection Guide

The standard starting dose of Trulicity is 0.75 mg once weekly by subcutaneous injection. This is the lowest available strength. For most patients, this dose is high enough to produce meaningful A1c improvement while minimizing the nausea that comes with starting a GLP-1 medication.

Clinical guidelines allow starting directly at 1.5 mg in some circumstances — for example, a patient switching from another GLP-1 who is already adapted to the class. However, most US prescribers start at 0.75 mg for at least the first 4 weeks to reduce the intensity of initial GI side effects. Starting high is associated with higher rates of nausea and vomiting.

Your clinician decides when to increase. As a general rule, dose increases are considered when: (1) you have been at the current dose for at least 4 weeks, (2) side effects have settled to a tolerable level, and (3) your A1c has not yet reached your target. Do not increase your own dose by using a different pen strength on your own — all dose changes should be made by a prescriber.

No. 4.5 mg is the highest FDA-approved weekly dose. Patients who need more glycemic control than 4.5 mg provides are typically evaluated for an add-on diabetes medication (basal insulin, an SGLT2 inhibitor) or for a switch to a different GLP-1 or dual GIP/GLP-1 agonist such as Mounjaro (tirzepatide), which has a higher ceiling.

In AWARD-11, patients on 4.5 mg experienced an additional ~0.3–0.5% A1c reduction and about 1–2 kg (2–4 lb) additional weight loss compared to 1.5 mg, but GI side effects were also more pronounced. Whether the additional benefit is worth the additional side effects depends on your glycemic target, tolerability, and goals.

Within the Trulicity label, the 4.5 mg weekly dose produces the largest mean weight loss — roughly 9–11 pounds versus about 4–6 pounds at 1.5 mg, on average over a year. That said, the differences between 1.5 mg, 3.0 mg, and 4.5 mg are modest, and side effects scale with dose. The "best dose" is the one your clinician has chosen based on your overall diabetes care, not a self-selected "weight loss dose."

You can have the conversation, but clinicians are generally cautious about titrating up purely for weight loss in patients whose diabetes is already well controlled on a lower dose. If weight loss is the primary goal, a more productive discussion is usually about switching to a medication specifically FDA-approved for chronic weight management. See our Trulicity weight loss guide for the full comparison.

You can safely lift the pen off your skin any time after the second click. Eli Lilly's instructions recommend making sure you've heard both clicks and that the grey plunger is visible in the viewing window before removing the pen. Some patients find that waiting an extra 2–3 seconds after the second click gives them more confidence that the full dose has been delivered.

Most patients describe the Trulicity injection as a brief pinch, less painful than a typical insulin injection because the needle is very thin and is deployed automatically. Some discomfort at the injection site — mild burning, redness, itching — can occur and usually resolves within minutes to hours. If you experience significant pain, swelling, or bruising that persists beyond a day, notify your clinician.

The abdomen is the most popular self-injection site because it is easy to see and reach, tends to have a stable layer of subcutaneous fat, and has consistent absorption. Rotating week to week — for example, right abdomen one week, left abdomen the next, thigh the third week — helps prevent injection-site reactions and lipohypertrophy over long-term use.

The buttock is not an approved Trulicity injection site in the US label. Stick with the abdomen, thigh, or back of upper arm as specified in the patient instructions.

No. Despite popular claims, there is no clinical evidence that injecting Trulicity in one approved site produces more weight loss than another. The pharmacokinetics — how quickly the drug is absorbed and how long it stays in the body — are similar across the abdomen, thigh, and upper arm. Social-media advice telling patients to inject in "the belly for more weight loss" is not supported by the FDA label or by clinical data.

Adherence to the weekly schedule, diet, physical activity, sleep, and whether the dose is appropriate for your goals. Trulicity produces only modest weight loss on average (roughly 3–5% of body weight); if that's not enough for your goals, the biggest lever is a discussion with a clinician about whether a different medication class is appropriate.

Yes. For short trips (up to 14 days), Trulicity can be stored at room temperature provided it stays below 86°F. For longer travel, use an insulated medication travel case with ice packs — never pack Trulicity pens in checked luggage (where they can freeze) and never expose them to direct sunlight or hot car interiors. If you travel internationally, carry the pens in your original labeled packaging along with your prescription for border checks.

If you remember the missed dose within 3 days (72 hours) of your scheduled injection day, inject the dose as soon as possible and then resume your normal weekly schedule from that point — either continue on the new day or go back to your original day at the next cycle, whichever your clinician prefers. If more than 3 days have passed, skip the missed dose and take your next dose on the regular schedule. Do not double up.

Yes, with one rule: the day between two consecutive doses must be at least 3 days. For example, if you normally inject on Monday and want to move to Friday, you can inject on Friday as long as your last Monday dose was at least 3 days earlier.